Skip to main content
. 2019 Nov 14;9:16787. doi: 10.1038/s41598-019-53098-1

Figure 1.

Figure 1

PRAS40 inhibits mTORC1 signaling in endothelial cells. (a,b) Representative immunoblot for indicated proteins after siRNA-mediated knockdown of PRAS40 in HUVECs and statistical analysis for indicated proteins based on analysis of 3 individual biological replicates. Data represent mean ± SEM; ***P < 0.001; ****P < 0.0001 (two-tailed student’s t-test). (c,d) Representative immunoblot for indicated proteins after adenoviral overexpression of PRAS40 in HUVECs and statistical analysis for indicated proteins based on analysis of 3 individual biological replicates. Data represent mean ± SEM; *P < 0.05; ****P < 0.0001 (two-tailed student’s t-test).